<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28455446</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>292</Volume><Issue>24</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-&#x3b1;1 degradation.</ArticleTitle><Pagination><StartPage>10262</StartPage><EndPage>10274</EndPage><MedlinePgn>10262-10274</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M116.745729</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) has emerged as one of the most important enteroviruses since the eradication of poliovirus, and it causes severe neurological symptoms for which no effective antiviral drugs are available. Type I interferons (IFN) &#x3b1;/&#x3b2; have been used clinically as antiviral therapy as the first line of defense against virus infections successfully for decades. However, treatment with type I interferons has not been effective in patients with EV71 infection. In this study, we found that in cells pretreated with IFN-&#x3b2;, EV71 infection could still lead to a cytopathic effect, and the viral replication was not affected. The mechanism by which EV71 antagonizes interferon signaling, however, has been controversial. Our study indicated that EV71 infection did not inhibit phosphorylation of STAT1/2 induced by IFN-&#x3b2; stimulation, but p-STAT1/2 transport into the nucleus was significantly blocked. We showed that EV71 infection reduced the formation of STAT/karyopherin-&#x3b1;1 (KPNA1) complex upon interferon stimulation and that the virus down-regulated the expression of KPNA1, a nuclear localization signal receptor for p-STAT1. Using specific caspase inhibitors and siRNA for caspase-3, we demonstrated that EV71 infection induced degradation of cellular KPNA1 in a caspase-3-dependent manner, which led to decreased induction of interferon-inducible genes and IFN response. Viral 2A and 3C proteases did not degrade KPNA1, inhibit the activity of ISRE or suppress the transcription of interferon-inducible genes induced by IFN-&#x3b2;. Our study demonstrates a novel mechanism by which antiviral signaling is suppressed through degradation of KPNA1 by activated caspase-3 induced in an enteroviral infection.</AbstractText><CopyrightInformation>&#xa9; 2017 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chunyang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Medical School and Jiangsu Provincial Key Laboratory of Medicine, Nanjing University, Nanjing 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Clinical Medical College, Xi'an Medical University, Xi'an 710021, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Nanjing Children's Hospital, Nanjing Medical University, Nanjing 210029, China, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Menghuai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Medical School and Jiangsu Provincial Key Laboratory of Medicine, Nanjing University, Nanjing 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Nanjing Children's Hospital, Nanjing Medical University, Nanjing 210029, China, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Xinhui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>From the Medical School and Jiangsu Provincial Key Laboratory of Medicine, Nanjing University, Nanjing 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Nanjing Children's Hospital, Nanjing Medical University, Nanjing 210029, China, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Lianfu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Medical School and Jiangsu Provincial Key Laboratory of Medicine, Nanjing University, Nanjing 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Nanjing Children's Hospital, Nanjing Medical University, Nanjing 210029, China, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Medical School and Jiangsu Provincial Key Laboratory of Medicine, Nanjing University, Nanjing 210008, China, jinyuldyy@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Nanjing Children's Hospital, Nanjing Medical University, Nanjing 210029, China, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardona</LastName><ForeName>Carol J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>the Department of Veterinary Biomedical Sciences, College of Veterinary Medicine, University of Minnesota at Twin Cities, St. Paul, Minnesota 55108.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>From the Medical School and Jiangsu Provincial Key Laboratory of Medicine, Nanjing University, Nanjing 210008, China, zxing@umn.edu zxing@nju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>the Department of Veterinary Biomedical Sciences, College of Veterinary Medicine, University of Minnesota at Twin Cities, St. Paul, Minnesota 55108.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C423142">KPNA1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050794">STAT1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494079">STAT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050795">STAT2 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494084">STAT2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028901">alpha Karyopherins</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="C507904">JAK1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D053613">Janus Kinase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505407">CASP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020895" MajorTopicYN="N">Enterocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019073" MajorTopicYN="N">HT29 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053613" MajorTopicYN="N">Janus Kinase 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050794" MajorTopicYN="N">STAT1 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050795" MajorTopicYN="N">STAT2 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028901" MajorTopicYN="N">alpha Karyopherins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Janus kinase (JAK)</Keyword><Keyword MajorTopicYN="N">RNA virus</Keyword><Keyword MajorTopicYN="N">STAT transcription factor</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">protein expression</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest with the contents of this article</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28455446</ArticleId><ArticleId IdType="pmc">PMC5473229</ArticleId><ArticleId IdType="doi">10.1074/jbc.M116.745729</ArticleId><ArticleId IdType="pii">S0021-9258(20)40827-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong S. S., Yip C. C., Lau S. K., and Yuen K. Y. (2010) Human enterovirus 71 and hand, foot and mouth disease. Epidemiol. Infect. 138, 1071&#x2013;1089</Citation><ArticleIdList><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L., Lu J., Kung H.-F., He M.-L. (2011) The virology and developments toward control of human enterovirus 71. Crit. Rev. Microbiol. 37, 313&#x2013;327</Citation><ArticleIdList><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M. J., McMinn P., and Ooi M. H. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet 10, 778&#x2013;790</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Platanias L. C. (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375&#x2013;386</Citation><ArticleIdList><ArticleId IdType="pubmed">15864272</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell J. E. Jr., Kerr I. M., and Stark G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415&#x2013;1421</Citation><ArticleIdList><ArticleId IdType="pubmed">8197455</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber F., Kochs G., and Haller O. (2004) Inverse interference: how viruses fight the interferon system. Viral Immunol. 17, 498&#x2013;515</Citation><ArticleIdList><ArticleId IdType="pubmed">15671747</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson C. L., and Gale M. Jr. (2006) CARD games between virus and host get a new player. Trends Immunol. 27, 1&#x2013;4</Citation><ArticleIdList><ArticleId IdType="pubmed">16309964</ArticleId></ArticleIdList></Reference><Reference><Citation>Katze M. G., He Y., and Gale M. Jr. (2002) Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2, 675&#x2013;687</Citation><ArticleIdList><ArticleId IdType="pubmed">12209136</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid S. P., Leung L. W., Hartman A. L., Martinez O., Shaw M. L., Carbonnelle C., Volchkov V. E., Nichol S. T., and Basler C. F. (2006) Ebola virus VP24 binds karyopherin &#x3b1;1 and blocks STAT1 nuclear accumulation. J. Virol. 80, 5156&#x2013;5167</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1472181</ArticleId><ArticleId IdType="pubmed">16698996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M. C., Kung H. F., and He M. L. (2012) Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 86, 3767&#x2013;3776</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M. L., Lee Y. P., Wang Y. F., Lei H. Y., Liu C. C., Wang S. M., Su I. J., Wang J. R., Yeh T. M., Chen S. H., and Yu C. K. (2005) Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 86, 3263&#x2013;3269</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L., He Y., Chen Y., Kung H. F., and He M. L. (2011) Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir. Ther. 16, 51&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis S., Jouanguy E., Al-Hajjar S., Fieschi C., Al-Mohsen I. Z., Al-Jumaah S., Yang K., Chapgier A., Eidenschenk C., Eid P., Al Ghonaium A., Tufenkeji H., Frayha H., Al-Gazlan S., Al-Rayes H., et al. (2003) Impaired response to interferon-&#x3b1;/&#x3b2; and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388&#x2013;391</Citation><ArticleIdList><ArticleId IdType="pubmed">12590259</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride K. M., Banninger G., McDonald C., and Reich N. C. (2002) Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-&#x3b1;. EMBO J. 21, 1754&#x2013;1763</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125956</ArticleId><ArticleId IdType="pubmed">11927559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi C., Sun Q., Wang S., Zhang Z., Li X., Cardona C. J., Jin Y., and Xing Z. (2013) Robust antiviral responses to enterovirus 71 infection in human intestinal epithelial cells. Virus Res. 176, 53&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pubmed">23685430</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Ji L., Yuan X., Jin Y., Cardona C. J., and Xing Z. (2016) Differential regulation of TLR signaling on the induction of antiviral interferons in human intestinal epithelial cells infected with enterovirus 71. PLoS One 11, e0152177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4805281</ArticleId><ArticleId IdType="pubmed">27007979</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Bi J., Liu J., Liu X., Wu X., Jiang P., Yoo D., Zhang Y., Wu J., Wan R., Zhao X., Guo L., Sun W., Cong X., Chen L., et al. (2014) 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation. J. Virol. 88, 4908&#x2013;4920</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3993825</ArticleId><ArticleId IdType="pubmed">24554650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Xue Q., Jin Q., He B., and Wang J. (2013) Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 87, 1690&#x2013;1698</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Sun Z., Liu X., Jin Q., He B., and Wang J. (2011) Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85, 8811&#x2013;8818</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., He B., and Wang J. (2010) The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 84, 8051&#x2013;8061</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R. L., Kao L. T., Lin S. J., Wang R. Y., and Shih S. R. (2013) MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One 8, e63431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang Z., Zhao X., Yu R., Zhang X., Wu S., Liu J., Chi X., Song X., Fu L., Yu Y., Hou L., and Chen W. (2014) Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol. 27, 267&#x2013;276</Citation><ArticleIdList><ArticleId IdType="pubmed">24905060</ArticleId></ArticleIdList></Reference><Reference><Citation>Chook Y. M., and Blobel G. (2001) Karyopherins and nuclear import. Curr. Opin. Struct. Biol. 11, 703&#x2013;715</Citation><ArticleIdList><ArticleId IdType="pubmed">11751052</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Edwards M. R., Borek D. M., Feagins A. R., Mittal A., Alinger J. B., Berry K. N., Yen B., Hamilton J., Brett T. J., Pappu R. V., Leung D. W., Basler C. F., and Amarasinghe G. K. (2014) Ebola virus VP24 targets a unique NLS binding site on karyopherin &#x3b1;5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe 16, 187&#x2013;200</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4188415</ArticleId><ArticleId IdType="pubmed">25121748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Nan Y., Yu Y., and Zhang Y. J. (2013) Porcine reproductive and respiratory syndrome virus Nsp1&#x3b2; inhibits interferon-activated JAK/STAT signal transduction by inducing karyopherin-&#x3b1;1 degradation. J. Virol. 87, 5219&#x2013;5228</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624296</ArticleId><ArticleId IdType="pubmed">23449802</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieman M., Yount B., Heise M., Kopecky-Bromberg S. A., Palese P., and Baric R. S. (2007) Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J. Virol. 81, 9812&#x2013;9824</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2045396</ArticleId><ArticleId IdType="pubmed">17596301</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Xi X., Lei X., Zhang X., Cui S., Wang J., Jin Q., and Zhao Z. (2013) Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathogens 9, e1003231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K. J., and Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(&#x2212;&#x394;&#x394;C(T)) method. Methods 25, 402&#x2013;408</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C., Oh B. H., and Jung J. U. (2015) Novel functions of viral anti-apoptotic factors. Nat. Rev. Microbiol. 13, 7&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4420620</ArticleId><ArticleId IdType="pubmed">25363821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh Roy S., Sadigh B., Datan E., Lockshin R. A., and Zakeri Z. (2014) Regulation of cell survival and death during Flavivirus infections. World J. Biol. Chem. 5, 93&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4050121</ArticleId><ArticleId IdType="pubmed">24921001</ArticleId></ArticleIdList></Reference><Reference><Citation>Best S. M., Wolfinbarger J. B., and Bloom M. E. (2002) Caspase activation is required for permissive replication of Aleutian mink disease parvovirus in vitro. Virology 292, 224&#x2013;234</Citation><ArticleIdList><ArticleId IdType="pubmed">11878925</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K. K., Posmantur R., Nath R., McGinnis K., Whitton M., Talanian R. V., Glantz S. B., and Morrow J. S. (1998) Simultaneous degradation of &#x3b1;II- and &#x3b2;II-spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem. 273, 22490&#x2013;22497</Citation><ArticleIdList><ArticleId IdType="pubmed">9712874</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xe9;v&#xf4;t D., Darlix J. L., and Ohlmann T. (2003) Conducting the initiation of protein synthesis: the role of eIF4G. Biol. Cell 95, 141&#x2013;156</Citation><ArticleIdList><ArticleId IdType="pubmed">12867079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhu Z., Yang W., Ren J., Tan X., Wang Y., Mao N., Xu S., Zhu S., Cui A., Zhang Y., Yan D., Li Q., Dong X., Zhang J., et al. (2010) An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol. J. 7, 94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xe4;rber G. (1931) Contribution to the collective treatment of pharmacological series tests. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol 162, 480&#x2013;483</Citation></Reference><Reference><Citation>Rubinsztein D. C. (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443, 780&#x2013;786</Citation><ArticleIdList><ArticleId IdType="pubmed">17051204</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>